Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
Clinical trial NCT05225415 · COMPLETED
Trial details
- NCT number
- NCT05225415
- Sponsor
- Cognition Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2024-11-25
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.